Prognostic Epigenetics

This volume provides comprehensive information on how mapping an individual’s epigenome can be medically relevant and holds the potential to improve preventive medicine and precision therapeutics at an early-stage (prior to disease onset). In order to advance clinical adoption of the recently developed epigenetic approaches, it is necessary for translational scientists, clinicians, and students to gain a better understanding about epigenetic mechanisms that are associated with a particular disorder; and to be able to effectively identify biomarkers that can be applied in drug development and for better diagnosis and prognosis of diseases.

Prognostic Epigenetics

• Compiles all known information on prognostic epigenetics and its role in preventive medicine and drug discovery
• Covers the basic functionality of epigenetic mechanisms involved in early disease prognosis and diagnosis, and provides tools for the identification and development of these biomarkers for a wide range of diseases
• Enables clinicians, researchers, and pharmacologists to improve preventive medicine and precision therapeutics throughout a person’s lifetime
• Features chapter contributions from leading international researchers

Translational researchers, clinicians and graduate students in genomic medicine, epigenetics, endocrinology, nutrition, oncology, pathology, and biotechnology; life science researchers; developmental biologists; MDs/clinicians, medical students and residents; pharmacologists in industry and academia; primary care doctors, medical chemists, molecular biologists, genetic counselors